Kidney Transplantation in a Patient With Hairy Cell Leukemia in Complete Remission: A Case Report

ABSTRACT Hairy cell leukemia (HCL) is a rare, indolent B‐cell neoplasm characterized by the BRAF V600E mutation. Kidney transplantation in patients with active or prior hematologic malignancy represents a complex clinical scenario with limited evidence on current guidelines. We report the first documented case of a patient that while undergoing kidney transplant evaluation was diagnosed with classic HCL. He was treated with vemurafenib and rituximab and achieved complete remission (CR). He subsequently underwent successful kidney transplantation and has remained in sustained CR with stable allograft function at 22 months of follow‐up. This case highlights the importance of individualized multidisciplinary transplant decision‐making. Trial Registration : The authors have confirmed clinical trial registration is not needed for this submission.

Authors

Institutions

Publication Details

Journal
eJHaem
Published
2026-11-13
DOI
https://doi.org/10.1002/jha2.70424
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Kidney Transplantation in a Patient With Hairy Cell Leukemia in Complete Remission: A Case Report

Vathany Sriganeshan, Fernando Poli de Frias, Jacqueline C. Barrientos, Francesca Polit et al.
1 links
eJHaem
Renal Transplantation Outcomes and Treatments
article

Kidney Transplantation in a Patient With Hairy Cell Leukemia in Complete Remission: A Case Report

Vathany Sriganeshan, Fernando Poli de Frias, Jacqueline C. Barrientos, Francesca Polit, Carla Romagnoli, Alexandra Lyubimova, Andrea Poli De Frias, Leily Santos
article en

Abstract

ABSTRACT Hairy cell leukemia (HCL) is a rare, indolent B‐cell neoplasm characterized by the BRAF V600E mutation. Kidney transplantation in patients with active or prior hematologic malignancy represents a complex clinical scenario with limited evidence on current guidelines. We report the first documented case of a patient that while undergoing kidney transplant evaluation was diagnosed with classic HCL. He was treated with vemurafenib and rituximab and achieved complete remission (CR). He subsequently underwent successful kidney transplantation and has remained in sustained CR with stable allograft function at 22 months of follow‐up. This case highlights the importance of individualized multidisciplinary transplant decision‐making. Trial Registration : The authors have confirmed clinical trial registration is not needed for this submission.

eJHaemVol. 7(6)
Mount Sinai Medical Center (US)
Good health and well-being
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon